Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roos S G Sablerolles

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|January 28, 2021
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 27, 2020
COvid MEdicaTion (COMET) study: protocol for a cohort studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Heliyon|December 17, 2024
Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19Julia Minnema, Melvin Lafeber, Roos S G Sablerolles, et al.
Trials|August 6, 2024
Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trialNgoc H Tan, Melvin Lafeber, Roos S G Sablerolles, et al.
The Lancet. Healthy Longevity|March 3, 2021
Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort studyRoos S G Sablerolles, Melvin Lafeber, Janneke A L van Kempen, et al.
Critical Care Medicine|February 10, 2023
Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19: A Nationwide Observational Cohort StudyCorstiaan A den Uil, Fabian Termorshuizen, Wim J R Rietdijk, et al.
Frontiers in Immunology|October 25, 2021
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial ProtocolRoos S G Sablerolles, Abraham Goorhuis, Corine H GeurtsvanKessel, et al.
AIDS (London, England)|May 24, 2024
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the NetherlandsMarlou J Jongkees, Ngoc H Tan, Daryl Geers, et al.
The New England Journal of Medicine|January 19, 2022
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S PrimingRoos S G Sablerolles, Wim J R Rietdijk, Abraham Goorhuis, et al.
Frontiers in Immunology|December 16, 2022
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocolNgoc H Tan, Roos S G Sablerolles, Wim J R Rietdijk, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|January 28, 2021
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 27, 2020
COvid MEdicaTion (COMET) study: protocol for a cohort studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Heliyon|December 17, 2024
Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19Julia Minnema, Melvin Lafeber, Roos S G Sablerolles, et al.
Trials|August 6, 2024
Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trialNgoc H Tan, Melvin Lafeber, Roos S G Sablerolles, et al.
The Lancet. Healthy Longevity|March 3, 2021
Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort studyRoos S G Sablerolles, Melvin Lafeber, Janneke A L van Kempen, et al.
Critical Care Medicine|February 10, 2023
Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19: A Nationwide Observational Cohort StudyCorstiaan A den Uil, Fabian Termorshuizen, Wim J R Rietdijk, et al.
Frontiers in Immunology|October 25, 2021
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial ProtocolRoos S G Sablerolles, Abraham Goorhuis, Corine H GeurtsvanKessel, et al.
AIDS (London, England)|May 24, 2024
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the NetherlandsMarlou J Jongkees, Ngoc H Tan, Daryl Geers, et al.
The New England Journal of Medicine|January 19, 2022
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S PrimingRoos S G Sablerolles, Wim J R Rietdijk, Abraham Goorhuis, et al.
Frontiers in Immunology|December 16, 2022
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocolNgoc H Tan, Roos S G Sablerolles, Wim J R Rietdijk, et al.
Pageof 2